WASHINGTON — The U.S. has approved the world’s only twice-a-year shot to prevent HIV, the first step in an anticipated global ...

Yeztugo, approved by the FDA, was highly effective in two randomized trials. It costs $28,218 per year, and people have to be ...

The National Institutes of Health office responsible for issuing federal guidelines related to treatment of HIV and AIDS ...

Like other PrEP drugs, if enough of the medication is present when a person is exposed to HIV, it can prevent the virus from ...

A new HIV prevention shot, approved by the FDA and taken just twice a year, could transform global care, but experts warn ...

He affirmed that the new drug "could take the epidemic to the history books," according to Mother Jones.Yeztugo, based on the ...

While Gilead Sciences' HIV prevention drug lenacapavir got approved by the US Food and Drug Administration (FDA), its made- ...

The Food and Drug Administration approved a new vaccine to prevent HIV infection, lenacapavir, a long-acting injection, which ...

These four BofA Securities Growth 10 stocks come with reliable dividends and are are timely ideas for growth and income ...

"It's very important history that's local to San Francisco." Community members and local leaders came together for a Pride ...